Brief: Amgen and TScan Therapeutics Announce Collaboration

Tscan Therapeutics

09/05/2023 14:11

May 9 (Reuters) - Amgen Inc  AMGN.O :
    * AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO
IDENTIFY
NOVEL TARGETS IN CROHN’S DISEASE
    * AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO
IDENTIFY
NOVEL TARGETS IN CROHN’S DISEASE
    * TSCAN THERAPEUTICS INC - TSCAN TO RECEIVE $30 MILLION
UPFRONT
WITH POTENTIAL DEVELOPMENT AND COMMERCIAL MILESTONE PAYMENTS OF
OVER $500 MILLION
    * TSCAN THERAPEUTICS INC - AMGEN WILL EVALUATE A VARIETY OF
MODALITIES TO CREATE THERAPEUTICS BASED ON TARGETS DISCOVERED BY
TSCAN
    * TSCAN THERAPEUTICS INC - AMGEN WILL RETAIN ALL GLOBAL
DEVELOPMENT AND COMMERCIAL RIGHTS
    * TSCAN THERAPEUTICS INC - AMGEN ALSO HAS AN OPTION TO
EXPAND
COLLABORATION TO ULCERATIVE COLITIS, UNDER CERTAIN TERMS
    * TSCAN THERAPEUTICS INC - EACH PARTY WILL BE RESPONSIBLE
FOR ITS
OWN RESEARCH EXPENSES

Source text for Eikon:  ID:nGNX1kXxfy 
Further company coverage:  AMGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))